LGALS3 and myocardial infarction: In experimental studies, rats with induced myocardial infarction had reduced myocardial fibrosis after administration of angiotensin-converting enzyme inhibitors and spironolactone (45), indicating that circulating galectin-3 levels could be influenced by the type of medical treatment administrated.